PRO OSTEON IMPLANT 500 POROUS CORALLINE HYDROXYAPATITE BONE GRAFT SUBSTITUTE

FDA Premarket Approval P860005 S010

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a change to the name of the product from "bone void filler" to "bone graft substitute. " the device, as modified in designation, will be marketed under the trade name "pro osteon implant 500 porous coralline hydroxyapatite bone graft substitute blocks and granules," and is indicated for the same indications approved in the original pma and in p860006/s002.

DevicePRO OSTEON IMPLANT 500 POROUS CORALLINE HYDROXYAPATITE BONE GRAFT SUBSTITUTE
Generic NameFiller, Bone Void, Non-osteoinduction
ApplicantINTERPORE INTL.
Date Received1997-11-18
Decision Date1998-01-08
PMAP860005
SupplementS010
Product CodeMBS 
Advisory CommitteeOrthopedic
Supplement TypeNormal 180 Day Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address INTERPORE INTL. 181 Technology Dr. irvine, CA 92618-2402

Supplemental Filings

Supplement NumberDateSupplement Type
P860005Original Filing
S012 2001-12-04 Normal 180 Day Track
S011 1999-04-22 Normal 180 Day Track
S010 1997-11-18 Normal 180 Day Track
S009 1997-10-27 Normal 180 Day Track
S008 1997-08-28 Normal 180 Day Track
S007 1997-05-15 Normal 180 Day Track
S006
S005 1996-04-29 Normal 180 Day Track
S004 1994-02-22 Normal 180 Day Track
S003 1993-10-15 Normal 180 Day Track
S002 1993-03-23 Normal 180 Day Track
S001 1993-02-08 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.